The purpose of this study was to investigate the tissue expression of GHR/STAT5/IGF-1 signaling pathway by immunohistochemistry (IHC) in HCV–associated HCC patients and to correlate the results with the clinico-pathological features and disease outcome. This evidence concerns the gene GHR and hepatocellular carcinoma.